Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] - N0000175820

Pharmacologic Class Information

Pharmacologic Code N0000175820
Pharmacologic Name Hydrolytic Lysosomal Glucocerebroside-specific Enzyme
Pharmacologic Uses
  • hydrolytic lysosomal glucocerebroside-specific enzyme
  • hydrolytic lysozomal glucocerebroside-specific enzyme
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Hydrolytic Lysosomal Glucocerebroside-specific Enzyme

The following table contains 3 products whose active ingredient are classified under the same pharmacologic class Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0069-0106Elelyso Non-Proprietary Name: Taliglucerase AlfaInjection, Powder, Lyophilized, For SolutionIntravenousPfizer Laboratories Div Pfizer IncACTIVE
54092-701Vpriv Non-Proprietary Name: Velaglucerase AlfaInjection, Powder, Lyophilized, For SolutionIntravenousTakeda Pharmaceuticals America, Inc.ACTIVE
58468-4663Cerezyme Non-Proprietary Name: ImigluceraseInjection, Powder, Lyophilized, For SolutionIntravenousGenzyme CorporationACTIVE